# Ultrasound-Guided Injection of Sacroiliac Joint in Dogs for Pain Management


## Key Takeaways

- Ultrasound guidance offers a real-time, radiation-free alternative to fluoroscopy or CT for sacroiliac (SI) joint injections in dogs, requiring a working knowledge of pelvic girdle anatomy and appropriate ultrasound equipment (curvilinear or microconvex transducer, 5-10 MHz range).
- The primary indication for SI joint injection is suspected SI joint pain contributing to pelvic limb lameness or lumbosacral discomfort, with diagnostic blockade using local anesthetic being the most defensible initial approach to confirm the joint as a pain generator.
- A dorsal, craniocaudal oblique needle trajectory is preferred, targeting the dorsolateral joint space identified by the dorsal border of the ilial wing and sacral wing, with confirmation of needle tip placement achieved through real-time visualization and optional contrast or air microbubble testing.
- Injectate options include local anesthetic alone for diagnostic blockade or a combination of local anesthetic and corticosteroid for therapeutic effect, with volumes typically ranging from 0.5 to 1.5 mL depending on patient size, and contraindications including coagulopathy and local infection.
- Post-procedural care involves restricted activity for 24-48 hours, monitoring for transient worsening or signs of nerve root involvement, and careful documentation of the procedure, including imaging, injectate, and outcomes, to support diagnostic reasoning and future comparisons.
- Common complications include extra-articular deposition of injectate, vascular uptake, and nerve root contact, which can be mitigated by meticulous technique, real-time Doppler assessment, and careful needle advancement, with corrective actions involving needle repositioning or redirection.

---

This article describes the ultrasound-guided technique for injecting the sacroiliac (SI) joint in dogs as part of a multimodal pain management strategy. It is written for practicing veterinarians who perform diagnostic imaging and interventional procedures and who seek a structured approach to a joint that is technically challenging to access. The content covers relevant anatomy, patient selection, imaging landmarks, needle placement, injectate choices, and aftercare, with attention to the evidence base that informs each step. The focus is procedural and does not extend to surgical fusion or other open interventions.

Chronic pain affecting the pelvic limb and lumbosacral region is a common clinical problem in dogs, and the SI joint is increasingly recognized as a potential contributor. Ultrasound guidance offers a real-time, radiation-free alternative to fluoroscopy or CT for periarticular and intra-articular injections. The technique requires a working knowledge of the osseous and soft-tissue anatomy of the pelvic girdle, a suitable ultrasound machine with a curvilinear or microconvex transducer, and a clear plan for confirming needle position before injection.

The clinical question this article answers is practical: how does the operator identify the SI joint reliably, place a needle safely, and select an injectate that serves the diagnostic or therapeutic goal? Where the veterinary evidence is limited, the discussion draws on principles from human interventional pain medicine, particularly the [consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group](https://pubmed.ncbi.nlm.nih.gov/32245841/), and acknowledges where extrapolation is required.

## At a Glance

| Parameter | Decision or Fact |
|---|---|
| Primary indication | Suspected SI joint pain contributing to pelvic limb lameness or lumbosacral discomfort |
| Imaging modality | Ultrasound with curvilinear or microconvex transducer, 5 to 10 MHz range |
| Patient positioning | Sterna recumbency with pelvic limbs extended caudally, or lateral recumbency with the affected side uppermost |
| Key landmark | Dorsal border of the ilial wing and the sacral wing, identified in a dorsal oblique plane |
| Needle approach | Dorsal, craniocaudal oblique trajectory directed toward the dorsolateral joint space |
| Confirmation of placement | Real-time visualization of needle tip adjacent to the joint margin, optional contrast or air microbubble test |
| Injectate options | Local anesthetic alone for diagnostic blockade, local anesthetic plus corticosteroid for therapeutic effect |
| Aftercare | Restricted activity for 24 to 48 hours, monitor for transient worsening or signs of nerve root involvement |
| Contraindications | Coagulopathy, local infection, known hypersensitivity to injectate components |

## Anatomy of the Canine Sacroiliac Joint

The SI joint in dogs is a synovial articulation between the auricular surface of the ilium and the corresponding surface of the sacral wing. It is a relatively immobile joint, but it contains a true joint capsule, a synovial membrane, and a narrow joint space that is oriented obliquely in three planes. The dorsal aspect of the joint is covered by the strong dorsal sacroiliac ligament, which must be considered when planning a needle trajectory. Ventrally, the joint relates to the lumbosacral trunk and the internal iliac vessels, structures that lie at a distance but must be kept in mind during needle advancement.

The joint space itself is narrow, often less than 1 to 2 mm in the dog, which makes intra-articular injection technically demanding. Many clinical injections are therefore periarticular, depositing injectate within the joint capsule and along the dorsal ligamentous complex. This distinction matters for interpretation: a periarticular injection may still provide clinical benefit, but it does not confirm intra-articular placement in the same way that arthrography or contrast-enhanced imaging would.

The dorsal approach is preferred because it avoids the major neurovascular structures that run ventral to the joint. The ilial wing provides a broad bony acoustic window, and the sacral wing is identifiable as a distinct hyperechoic contour with a characteriztic step-off at the joint margin. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides general reference material on canine musculoskeletal anatomy and pain assessment that supports this procedural framework.

## Rationale for Ultrasound Guidance

Ultrasound guidance offers several advantages over blind or landmark-based injection. It allows real-time visualization of the needle tip, identification of individual soft-tissue layers, and avoidance of the sciatic nerve and gluteal vasculature. It also permits dynamic assessment of the joint during positioning, which can help the operator confirm that the intended target is indeed the SI joint and not the adjacent lumbosacral facet or the coxofemoral joint.

Compared with fluoroscopy, ultrasound avoids ionizing radiation and does not require specialized radiology facilities. The [American College of Veterinary Radiology resources](https://acvr.org/) describe the standards for diagnostic imaging practice, including the expectation that image-guided procedures be performed with adequate training and documentation. Ultrasound does have limitations: the acoustic window is narrow, the joint space is small, and obese or heavily muscled patients may degrade image quality. Operator experience is therefore a significant factor in success.

The evidence base for ultrasound-guided SI joint injection in dogs is limited to case series and expert opinion. In human medicine, the [interventional therapies for chronic low back pain focused review](https://pubmed.ncbi.nlm.nih.gov/26484298/) notes that image guidance is considered standard for spinal and sacroiliac procedures because it improves accuracy and reduces complication rates. The same logic applies to veterinary patients, although direct comparative studies in dogs are lacking.

## Patient Selection and Diagnostic Reasoning

Candidates for SI joint injection are dogs with clinical signs referable to the pelvic girdle that have not responded adequately to conservative management. Typical signs include unilateral pelvic limb lameness, pain on palpation or manipulation of the sacroiliac region, and reluctance to rise or jump. These signs overlap considerably with lumbosacral disease, coxofemoral osteoarthritis, and iliopsoas strain, so a thorough orthopedic and neurologic examination is mandatory before considering injection.

Diagnostic blockade is the most defensible indication for SI joint injection. A positive response, defined as a measurable improvement in gait or pain scores within 15 to 30 minutes of injecting a short-acting local anesthetic, supports the SI joint as a pain generator. A negative response does not exclude SI joint pain, because periarticular placement may fail to anesthetize the joint fully. The [consensus practice guidelines on interventions for lumbar facet joint pain](https://pubmed.ncbi.nlm.nih.gov/32245841/) emphasize that diagnostic blocks must be interpreted with attention to false positives and false negatives, a principle that applies equally to the SI joint.

Therapeutic injection is offered when diagnostic blockade is positive or when the clinical picture is strongly suggestive despite a negative block. Repeated injections are generally discouraged unless the response to the first injection is substantial and durable. The decision to proceed with a second or third injection should be based on documented improvement in objective outcome measures, such as force plate gait analysis or validated pain scoring instruments, instead of owner impression alone.

## Pharmacology of Injectates

The two main classes of injectate are local anesthetics and corticosteroids. Local anesthetics provide rapid, reversible blockade of nociceptive transmission and are used primarily for diagnosis. The choice of agent depends on the desired duration of blockade and the availability of formulations. Corticosteroids are added for therapeutic effect, targeting inflammatory mediators within the joint and periarticular tissues. The combination of a local anesthetic and a corticosteroid is common in clinical practice, although the evidence for corticosteroid efficacy at the SI joint specifically is extrapolated from other synovial joints.

Current formulary and label references must be consulted for drug selection, concentration, and volume, because these vary by product and jurisdiction. The [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on the responsible use of therapeutic agents in veterinary practice, including considerations for extralabel drug use where applicable. No specific dose is presented here as universal instruction.

## Procedural Principles

The procedure is performed under sedation or general anesthesia, depending on patient temperament and the need for absolute stillness. Aseptic preparation of the skin over the sacral and ilial region is essential. The operator stands on the side of the affected joint and positions the transducer in a dorsal oblique plane to identify the ilial wing and sacral wing. The needle is introduced cranial to the transducer and advanced in a caudoventral direction toward the joint margin, with continuous visualization of the needle shaft and tip.

Confirmation of placement is achieved by observing the needle tip adjacent to the joint space and by injecting a small volume of air or sterile saline to create a hyperechoic microbubble cloud. If contrast imaging is available, a CT or fluoroscopic confirmation can be performed, but this is not always necessary in a clinical setting. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) do not address this procedure directly, but they underscore the importance of documenting procedures and outcomes in clinical practice.

## Equipment and Consumable Selection

The ultrasound machine should have a linear array transducer with a frequency range of 7 to 15 MHz for medium and large breed dogs. Small breeds and thin patients may require higher frequencies up to 18 MHz, while deep-chested or heavily muscled dogs may benefit from a microconvex probe to improve acoustic access. The transducer must be capable of producing a clear image at depths of 2 to 6 cm, depending on patient size.

Needle selection follows standard interventional principles. A 22 gauge spinal needle of 3.5 to 7.5 cm length is appropriate for most patients. The needle should have a stylet to prevent coring of tissue and to confirm that the tip has not entered a vessel. Echogenic needle tips, either commercially manufactured or created by roughening the distal 2 to 3 mm with a scalpel blade, improve tip visualization during the procedure.

Sterile ultrasound gel, chlorhexidine or povidone-iodine solution, and sterile probe covers are required. A sterile sleeve with gel inside the cover maintains acoustic coupling. The operator should use sterile gloves and a no-touch technique for the needle hub. Local anesthetic for the skin and subcutaneous tract, such as lidocaine or bupivacaine, is drawn up separately from the injectate to avoid contamination.

The injectate is prepared according to the plan established in the pharmacology section. A three-way stopcock and extension tubing allow a second operator to aspirate and inject without moving the needle. This is particularly valuable when the needle tip is positioned within the joint space and any movement risks displacement.

## Patient Preparation and Positioning

The patient is premedicated with an opioid and a sedative that provides muscle relaxation. Acepromazine or dexmedetomidine are commonly used, but the choice depends on cardiovascular status and the degree of pain-related muscle guarding. General anesthesia is preferred for patients that cannot remain still, for those with severe hip or back pain, and when bilateral injections are planned. The procedure can be performed under deep sedation with local anesthesia in cooperative patients, but the operator must accept that patient movement during needle placement increases the risk of iatrogenic injury.

The patient is positioned in lateral recumbency with the affected side uppermost. The dependent pelvic limb is pulled slightly cranially and the uppermost limb is positioned in a neutral, relaxed stance. A vacuum bag or sandbag placed under the pelvis helps stabilize the patient. The sacral region is clipped from the dorsal midline to the greater trochanter and from the cranial aspect of the ilium to the ischiatic tuberosity. Aseptic preparation follows standard surgical protocols.

The operator stands dorsal to the patient with the ultrasound machine positioned on the opposite side, allowing direct visualization of the screen without twisting. The transducer is held in the non-dominant hand and the needle in the dominant hand. This arrangement permits fine adjustments of the transducer while maintaining steady needle control.

## Ultrasound Landmarks and Needle Placement

The sacroiliac joint is identified using a systematic approach. Place the transducer in a transverse plane over the dorsal midline at the level of the sacral wings. The dorsal spinous processes of the sacrum appear as hyperechoic linear structures with acoustic shadowing. Slide the transducer laterally until the ilial wing comes into view. The sacroiliac joint appears as a hypoechoic cleft between the hyperechoic sacral wing medially and the ilial wing laterally.

The joint space is narrow, typically 1 to 3 mm in the dog. The dorsal aspect of the joint is the target for injection because it is more accessible and carries less risk to the lumbosacral trunk, which lies ventral to the joint. The dorsal sacroiliac ligament covers the dorsal joint margin and appears as a thin hyperechoic band.

Two approaches are described: the dorsal parasagittal approach and the caudocranial approach. The dorsal parasagittal approach is more commonly used and is described here.

With the transducer in a transverse orientation over the joint, identify the cleft between the ilial wing and the sacral wing. The needle is inserted approximately 1 to 2 cm lateral to the transducer midline, angled approximately 30 to 45 degrees medially and slightly cranially. The needle tip is advanced under real-time ultrasound guidance until it contacts the dorsal joint margin. A loss of resistance may be felt as the needle penetrates the joint capsule.

Confirmation of intra-articular placement is achieved by injecting a small volume, 0.1 to 0.2 mL, of injectate and observing hydrodissection of the joint space. The injectate appears as an anechoic fluid collection that expands the joint cleft. If the injectate pools in the periarticular tissues, the needle tip is repositioned.

The caudocranial approach is used when the dorsal parasagittal approach is obstructed by the ilial wing or when the joint is particularly narrow. The transducer is placed in a sagittal plane over the caudal aspect of the ilial wing. The needle is inserted caudal to the transducer and directed cranially toward the joint. This approach follows the natural orientation of the joint surfaces and may be easier in deep-chested breeds.

## Intraprocedural Monitoring and Documentation

Continuous electrocardiography, pulse oximetry, and capnography are indicated when general anesthesia is used. Blood pressure monitoring is recommended because the injectate may contain local anesthetic or corticosteroid that can cause transient cardiovascular effects. The patient's heart rate and rhythm should be observed for 5 minutes after injection to detect systemic absorption of local anesthetic.

The volume of injectate is limited by the joint capacity. The canine sacroiliac joint accepts 0.5 to 1.5 mL depending on patient size. Overdistension of the joint causes pain and may rupture the joint capsule. The operator should feel resistance to injection when the joint is full. If more than the expected volume is injected without resistance, the needle tip is likely extra-articular.

Documentation should include the patient identification, the indication for the procedure, the ultrasound findings, the approach used, the needle gauge and length, the injectate composition and volume, the number of attempts, and any complications. Still images or video clips of the needle tip within the joint and the hydrodissection of the joint space should be saved to the patient record. This documentation supports the diagnostic reasoning and provides a baseline for future comparison if the procedure is repeated.

The patient is recovered in a quiet area with the pelvic limb supported. Weight bearing is restricted for 24 hours to allow the joint capsule to seal and to prevent displacement of the injectate. Non-steroidal anti-inflammatory drugs are continued according to the pain management plan. The owner is advised to restrict jumping, stair climbing, and vigorous play for 3 to 5 days.

## Decision Points That Change the Procedure

Patient size changes the transducer frequency and needle length. Patients under 10 kg may require a higher frequency transducer and a 3.5 cm needle. Patients over 40 kg may require a lower frequency transducer and a 7.5 cm needle. The operator should select equipment based on the measured distance from skin to joint, not on body weight alone.

Bilateral disease is common in dogs with degenerative sacroiliac disease. Bilateral injection can be performed in a single anesthetic episode, but the total injectate volume must be adjusted to avoid systemic toxicity from local anesthetic or corticosteroid. The operator should consider whether the patient's pain is symmetrical and whether the second side should be injected at the same session or at a separate session.

The presence of severe osteoarthritis with periarticular osteophytes may make the joint space difficult to identify. In these cases, the operator should consider CT guidance, which provides superior bony detail and allows precise needle placement. The [American College of Veterinary Radiology resources](https://acvr.org/) describe the standards for image-guided interventional procedures and the training expected of operators performing them.

The evidence base for sacroiliac joint injection in dogs is limited. The procedure is adapted from human pain management, where the [consensus practice guidelines on interventions for lumbar facet joint pain](https://pubmed.ncbi.nlm.nih.gov/32245841/) emphasize the importance of diagnostic blocks before therapeutic intervention. A similar approach is reasonable in dogs: a diagnostic block with local anesthetic alone can confirm the joint as a pain source before a therapeutic injection with corticosteroid is performed. The [interventional therapies for chronic low back pain review](https://pubmed.ncbi.nlm.nih.gov/26484298/) notes that proper diagnosis is required for appropriate intervention to provide optimal benefits, a principle that applies equally to canine patients.

If the patient does not respond to a well-placed injection, the operator should question the diagnosis instead of repeat the procedure. Alternative sources of pelvic or hindlimb pain include hip joint disease, lumbosacral disease, and iliopsoas muscle strain. Reassessment with orthogonal radiographs, advanced imaging, and a thorough orthopedic and neurologic examination is indicated before further intervention.

## Complications and Failure Modes

The most frequently encountered complication is extra-articular deposition of injectate. The dorsal and ventral sacroiliac ligamentous complex lies close to the joint space, and the joint itself is narrow, so injectate may track along fascial planes instead of distending the joint capsule. Early detection relies on real-time observation of injectate flow during the procedure. If flow is seen spreading dorsally or cranially along the iliac wing instead of distending the joint space, the needle tip should be repositioned before the full volume is delivered.

Vascular uptake is a second recognized failure mode. The cranial gluteal vessels and the iliolumbar vessels course near the dorsal aspect of the joint. Aspiration before injection reduces, but does not eliminate, the risk of intravascular placement, because the needle tip can move during the injection itself. Color Doppler interrogation of the needle tip immediately before injection is the most reliable discriminating check. If color fill is observed around the tip, the needle should be redirected.

Nerve root or lumbosacral trunk contact produces a characteriztic motor response in the ipsilateral hindlimb. This is more likely when the needle is directed too ventrally or caudally. The response may be subtle, particularly in heavily sedated patients, so the limb should be observed continuously during needle advancement and injection. If a motor response occurs, the needle should be withdrawn several millimetres and redirected dorsally.

Iatrogenic infection is uncommon but carries serious consequences. The sacroiliac region has limited soft tissue coverage, and a contaminated injection can seed the joint space or the adjacent vertebral canal. Strict aseptic technique, including clipping, surgical scrub, and sterile gel, is mandatory. Early signs of infection include worsening pain, pyrexia, and local swelling within 48 to 72 hours after the procedure.

| Observation | Likely cause | Discriminating check |
|---|---|---|
| Injectate spreads dorsally along iliac wing | Needle tip outside joint space, in periarticular fascia | Reposition tip, re-confirm bony landmarks, re-inject small test volume |
| Color fill at needle tip on Doppler | Intravascular placement | Redirect needle, re-scan with Doppler before injecting |
| Ipsilateral hindlimb twitch during advancement | Needle contact with lumbosacral trunk or nerve root | Withdraw needle, redirect dorsally, observe limb continuously |
| High resistance to injection | Needle tip in ligament or against bone | Slight withdrawal, rotate bevel, re-confirm position with probe rotation |
| Delayed onset of pain or swelling | Early infection or hematoma | Recheck patient within 72 hours, consider cytology or imaging |

## Common Errors and Corrective Action

The most common error in training is mistaking the dorsal iliac wing for the sacral wing. The two structures are separated by the sacroiliac joint line, which appears as a thin hyperechoic interface. Novice operators often place the needle too far dorsally, engaging the iliac wing and injecting into the periosteum. The corrective action is to identify the sacral foramina first, then move the probe laterally until the joint line is visible, and confirm the needle tip is ventral to the iliac wing margin.

A second frequent error is advancing the needle too deeply. The joint space is shallow, and the ventral aspect of the joint lies close to the pelvic canal. Over-advancement risks penetrating the pelvic fascia or contacting the lumbosacral trunk. The corrective action is to advance in small increments, using a short, steep approach angle, and to stop as soon as the needle tip is seen within the joint line on both sagittal and transverse planes.

A third error is failure to rotate the probe to confirm needle tip position in two planes. A needle tip that appears correctly placed in the sagittal plane may lie outside the joint in the transverse plane. The corrective action is to alternate between planes during advancement and to use the probe's built-in needle guide if available.

## Limitations of Current Evidence

The evidence base for ultrasound-guided sacroiliac joint injection in dogs is limited. Most published guidance is extrapolated from human interventional pain medicine, where the sacroiliac joint is a recognized target for diagnostic and therapeutic blocks. The [consensus practice guidelines on interventions for lumbar facet joint pain](https://pubmed.ncbi.nlm.nih.gov/32245841/) from a multispecialty international working group address facet joint procedures specifically and note that even in human medicine, the diagnostic value of single blocks is debated and that response criteria vary widely. The same uncertainty applies to the canine sacroiliac joint, where no equivalent consensus exists.

The [interventional therapies for chronic low back pain review](https://pubmed.ncbi.nlm.nih.gov/26484298/) emphasizes that proper diagnosis is required for appropriate intervention and that outcomes depend heavily on patient selection. In veterinary medicine, the lack of validated diagnostic criteria for sacroiliac joint pain means that patient selection is largely based on clinical examination, imaging findings, and response to prior therapy. Expert opinion differs on whether a diagnostic block should be performed before a therapeutic injection, and on how many injections constitute a reasonable trial before abandoning the approach.

There is also genuine uncertainty about the optimal injectate volume. The joint space is small, and volumes that are appropriate in human patients may cause capsular distension or extra-articular spread in dogs. Current practice is guided by extrapolation and clinical judgment instead of controlled studies.

## Referral and Escalation

Referral to a veterinary radiologist or a specialist in interventional pain management is appropriate when the operator cannot confidently identify the joint space on ultrasound, when the patient has atypical anatomy such as transitional vertebrae or prior pelvic trauma, or when a previous injection attempt has failed. Specialist consultation is also warranted when the patient has a coagulopathy, when there is concern for infection or neoplasia involving the sacroiliac region, or when the patient does not respond to an appropriately placed injection.

Laboratory involvement is indicated before the procedure in patients with suspected coagulopathy, in those on anticoagulant therapy, or when there is clinical suspicion of systemic disease affecting the joint. Platelet count, coagulation profile, and a complete blood count are the minimum baseline assessments. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides species-specific guidance on hematologic and coagulation testing and on the interpretation of abnormal results.

Regulatory reporting is rarely required for this procedure. If a serious adverse event occurs, such as infection, nerve injury, or a reaction to an injectate, the clinician should follow the reporting requirements of the relevant veterinary licensing body. The [American Veterinary Medical Association practice resources](https://www.avma.org/resources-tools) and the [World Organization for Animal Health terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) describe general obligations for adverse event reporting and professional conduct, though specific requirements vary by jurisdiction.

## Frequently Asked Questions

### How Many Attempts Should Be Allowed Before Abandoning Ultrasound-Guided Sacroiliac Injection?

Set a practical limit of two to three needle redirections per joint before reassessing the approach. If the needle tip cannot be visualized consistently or the injectate does not appear adjacent to the joint margin, stop and reposition the transducer or reconsider the patient's positioning. Repeated blind probing increases the risk of sciatic nerve contact or vascular puncture without improving accuracy. When landmarks remain unclear despite adjustment, consider referral for CT-guided placement or a diagnostic block performed under fluoroscopy. The evidence supporting image-guided spinal interventions in human medicine emphasizes that precise needle placement determines both diagnostic value and therapeutic outcome, so persistence without visual confirmation is not justified.

### What Can Be Done When a High-Frequency Linear Transducer Is Unavailable?

A microconvex transducer with a frequency range of 6 to 10 MHz is an acceptable alternative for medium and large breed dogs. The smaller footprint improves contact over the curved dorsal pelvis, although image resolution at the joint depth is reduced. In small breeds, a high-frequency linear array remains strongly preferred because the sacroiliac joint lies within 1 to 2 cm of the skin surface. If only a low-frequency curvilinear probe is available, the procedure should not be attempted, as the joint margins cannot be resolved reliably. The [American College of Veterinary Radiology resources](https://acvr.org/) provide guidance on transducer selection and image optimization for musculoskeletal applications.

### How Should the Procedure Be Documented in the Medical Record?

Record the patient's signalment, the clinical indication for the injection, the injectate used, and the volume delivered. Document the transducer type and frequency, the approach (caudal to cranial or cranial to caudal), the number of needle passes, and whether the needle tip was visualized within the joint space throughout injection. Note any resistance to injection, periarticular spread, or patient response during the procedure. Include post-procedural assessment of weight bearing and any immediate adverse events. The [AVMA practice resources](https://www.avma.org/resources-tools) outline general standards for medical record keeping that apply to interventional procedures, including accurate description of techniques and outcomes.

### Is This Technique Appropriate for Cats or Other Small Companion Animals?

The same ultrasound-guided approach can be adapted for cats, but the joint is considerably smaller and the depth is shallower. A high-frequency linear transducer of 15 MHz or higher is required, and the needle gauge should be reduced accordingly. The dorsal iliac wing is less prominent in cats, which makes the cranial landmark more difficult to identify. Published clinical experience in feline sacroiliac injection is limited, so extrapolation from canine technique carries uncertainty. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) notes species differences in pelvic anatomy that affect imaging approaches. For cats with suspected sacroiliac pain, consider CT-guided injection as the primary option if available, because the margin for error is smaller.

### How Should a Client Be Counseled About Expected Outcomes and Repeat Injections?

Explain that the procedure serves both diagnostic and therapeutic purposes, and that a single injection may not resolve chronic pain. Response typically becomes apparent within several days, and the duration of relief varies from weeks to months depending on the underlying pathology and the injectate selected. If the first injection provides substantial but temporary relief, a repeat injection can be considered, but more than two to three procedures per year should prompt reassessment of the diagnosis. The human literature on [interventional therapies for chronic low back pain](https://pubmed.ncbi.nlm.nih.gov/26484298/) shows that response to diagnostic blocks is highly variable and that therapeutic benefit depends on accurate patient selection. Set realistic expectations about activity modification and adjunctive analgesia during the recovery period.

### What Are the Cost and Resource Considerations for a General Practice?

The primary costs are the ultrasound equipment, the injectate, and the procedure time, which typically ranges from 20 to 40 minutes including positioning and aseptic preparation. Practices that already own a suitable ultrasound machine and perform other guided injections can offer this service without major capital investment. The main resource limitation is operator experience instead of equipment cost. For practices without an appropriate transducer or without a clinician trained in musculoskeletal ultrasound, referral to a specialty center is more cost-effective than attempting the procedure with inadequate imaging. The [consensus practice guidelines on image-guided spinal interventions](https://pubmed.ncbi.nlm.nih.gov/32245841/) emphasize that operator skill and image quality are the dominant factors determining procedural success and safety.

## Related Clinical & Scientific Guides

* [MRI Monitoring of Brain Tumor Response to Therapy in Dogs](/knowledge/veterinary-medicine/diagnostic-imaging/mri-monitoring-brain-tumor-response-therapy-dogs)
* [Ultrasound-Guided Drainage of Abscesses in Small Animals](/knowledge/veterinary-medicine/diagnostic-imaging/ultrasound-guided-drainage-abscesses-small-animals)
* [Radiographic Monitoring of Total Hip Replacement in Dogs](/knowledge/veterinary-medicine/diagnostic-imaging/radiographic-monitoring-total-hip-replacement-dogs)


## References and Further Reading

- [Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group.](https://pubmed.ncbi.nlm.nih.gov/32245841/). 2020.
- [Interventional Therapies for Chronic Low Back Pain: A Focused Review (Efficacy and Outcomes).](https://pubmed.ncbi.nlm.nih.gov/26484298/). 2015.
- [Long-term safety and effectiveness of the "OptEase" vena cava filter.](https://pubmed.ncbi.nlm.nih.gov/20820780/). 2011.
- [American College of Veterinary Radiology Resources](https://acvr.org/). American College of Veterinary Radiology.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.
- [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association.
- [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). WOAH.

## Related Articles

- [Ultrasound-Guided Injection of Stifle Joint in Dogs for Therapeutic Purposes](/knowledge/veterinary-medicine/diagnostic-imaging/ultrasound-guided-injection-stifle-joint-dogs-therapeutic)
- [CT-Guided Interventional Pain Management in Veterinary Practice](/knowledge/veterinary-medicine/diagnostic-imaging/ct-guided-interventional-pain-management-veterinary)
- [Ultrasound-Guided Cystocentesis for Therapeutic Drainage in Dogs and Cats](/knowledge/veterinary-medicine/diagnostic-imaging/ultrasound-guided-cystocentesis-therapeutic-drainage-dogs-cats)
- [Ultrasound-Guided Pericardiocentesis for Therapeutic Drainage in Dogs](/knowledge/veterinary-medicine/diagnostic-imaging/ultrasound-guided-pericardiocentesis-therapeutic-drainage-dogs)
- [Ultrasound-Guided Celiac and Mesenteric Nerve Block in Dogs](/knowledge/veterinary-medicine/diagnostic-imaging/ultrasound-guided-celiac-mesenteric-nerve-block-dogs)

> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.